SCHEMBL2835257

SCHEMBL2835257

COc1ccc(CC2(C(=O)O)CCC=CCCCCCNC(=O)[N+]3CC(Oc4nc(-c5ccc(F)cc5)nc5c(C)c(OC)ccc45)CC3C(=O)N2)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3552292 0.78 FAAH (0.31) —
SCHEMBL2837719 0.75 KCNH2 (0.31) —
SCHEMBL2839929 0.73 CTSS (0.32) —
SCHEMBL2833502 0.71 CTSS (0.32) —
SCHEMBL2839916 0.71 ALDH1A1 (0.33) —
SCHEMBL3552294 0.71 ADRB3 (0.47) —
SCHEMBL3552287 0.71 ADRB3 (0.47) —
SCHEMBL13501950 0.71 ADRB3 (0.47) —
SCHEMBL2835728 0.68 ADRB3 (0.42) —
SCHEMBL2843221 0.68 ADRB3 (0.46) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1912981-B1 MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS TIBOTEC PHARM LTD (IE) 2010-01-20 — — EP disclosed
Send feedback